Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder
Cleo L. Crunelle, Wim van den Brink, Franz Moggi, et al.
European Addiction Research (2018) Vol. 24, Iss. 1, pp. 43-51
Open Access | Times Cited: 144

Showing 1-25 of 144 citing articles:

The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder
Stephen V. Faraone, Tobias Banaschewski, David Coghill, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 128, pp. 789-818
Open Access | Times Cited: 907
Updated European Consensus Statement on diagnosis and treatment of adult ADHD
J. J. Sandra Kooij, Denise Bijlenga, Luana Salerno, et al.
European Psychiatry (2018) Vol. 56, Iss. 1, pp. 14-34
Open Access | Times Cited: 494
Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases
Zheng Chang, Laura Ghirardi, Patrick D. Quinn, et al.
Biological Psychiatry (2019) Vol. 86, Iss. 5, pp. 335-343
Open Access | Times Cited: 134
Alcohol use disorders and ADHD
Mathias Luderer, Josep Antoni Ramos‐Quiroga, Stephen V. Faraone, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 128, pp. 648-660
Closed Access | Times Cited: 63
Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
Rafał Jaeschke, Ewelina Sujkowska, Magdalena Sowa-Kućma
Psychopharmacology (2021) Vol. 238, Iss. 10, pp. 2667-2691
Open Access | Times Cited: 46
Treatment retention and abstinence of patients with substance use disorders according to addiction severity and psychiatry comorbidity: A six-month follow-up study in an outpatient unit
Constanza Daigre, Laia Rodríguez, Carlos Roncero, et al.
Addictive Behaviors (2021) Vol. 117, pp. 106832-106832
Closed Access | Times Cited: 42
Chronic Pain and Psychiatric Conditions
Keira J.A. Johnston, Laura M. Huckins
Complex Psychiatry (2022) Vol. 9, Iss. 1-4, pp. 24-43
Open Access | Times Cited: 29
Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician
Margherita Barbuti, Marco Maiello, Vincenza Spera, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3096-3096
Open Access | Times Cited: 22
Association Between Stimulant Treatment and Substance Use Through Adolescence Into Early Adulthood
Brooke S. G. Molina, Traci M. Kennedy, Howard E. Barbaree, et al.
JAMA Psychiatry (2023) Vol. 80, Iss. 9, pp. 933-933
Open Access | Times Cited: 21
International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder
Heval Özgen, Renske Spijkerman, Moritz Noack, et al.
European Addiction Research (2020) Vol. 26, Iss. 4-5, pp. 223-232
Open Access | Times Cited: 42
Rodent models of attention-deficit hyperactivity disorder: An updated framework for model validation and therapeutic drug discovery
Kathleen M. Kantak
Pharmacology Biochemistry and Behavior (2022) Vol. 216, pp. 173378-173378
Closed Access | Times Cited: 24
Hospitalization Associated With Comorbid Psychiatric and Substance Use Disorders Among Adults With COVID-19 Treated in US Emergency Departments From April 2020 to August 2021
Lyna Z. Schieber, Christopher Dunphy, Richard A. Schieber, et al.
JAMA Psychiatry (2023) Vol. 80, Iss. 4, pp. 331-331
Open Access | Times Cited: 13
Prevalence and clinical phenotypes of adult patients with attention deficit hyperactivity disorder and comorbid behavioral addictions
Giacomo Grassi, Corinna Moradei, Chiara Cecchelli
Journal of Behavioral Addictions (2024) Vol. 13, Iss. 2, pp. 473-481
Open Access | Times Cited: 5
Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement
Susan Young, Cyrus Abbasian, Zainab Al‐Attar, et al.
World Journal of Psychiatry (2023) Vol. 13, Iss. 3, pp. 84-112
Open Access | Times Cited: 11
A systematic review and meta-analysis of health, functional, and cognitive outcomes in young people who use methamphetamine
Alexandre Guerin, Tahnee Bridson, Helena Plapp, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 153, pp. 105380-105380
Open Access | Times Cited: 11
Association between Executive Function and Food Addiction among Children and Adolescents with Attention Deficit Hyperactivity Disorder
Lun Meng, Na Li, Tao Chen, et al.
Appetite (2025), pp. 107884-107884
Closed Access
ADHD and Alcohol Use Disorder: Optimizing Screening and Treatment in Co-occurring Conditions
Mariely Hernández, Frances R. Levin, Aimee Campbell
CNS Drugs (2025)
Closed Access
The Use of Novel Stimulants in ADHD Self-Medication: A Mixed Methods Analysis
Tayler Holborn, Fabrizio Schifano, Emma Smith, et al.
Brain Sciences (2025) Vol. 15, Iss. 3, pp. 292-292
Open Access
Dual Diagnosis
Ebony Caldwell, Crystal Obiozor, Monthe Kofos, et al.
Elsevier eBooks (2025)
Closed Access
Commentary on Young et al.: Clinical guidance is required for stimulant co‐prescription with opioid agonist therapy
Nadine Ezard, Krista J. Siefried, Brendan Clifford
Addiction (2025)
Open Access
Drug Treatment of other Psychiatric Conditions

(2025), pp. 787-802
Closed Access
Prevalence of cocaine use and cocaine use disorder among adult patients with attention-deficit/hyperactivity disorder: A systematic review and meta-analysis
Francesco Oliva, C. Mangiapane, Gabriele Nibbio, et al.
Journal of Psychiatric Research (2020) Vol. 143, pp. 587-598
Open Access | Times Cited: 32
Association of Opioid and Stimulant Use Disorder Diagnoses With Fatal and Nonfatal Overdose Among People With a History of Incarceration
Heather Palis, Wen Qi Gan, Chloé G. Xavier, et al.
JAMA Network Open (2022) Vol. 5, Iss. 11, pp. e2243653-e2243653
Open Access | Times Cited: 17
ADHD and Substance Use Disorders in Young People
Daria Taubin, Julia C. Wilson, Timothy E. Wilens
Child and Adolescent Psychiatric Clinics of North America (2022) Vol. 31, Iss. 3, pp. 515-530
Open Access | Times Cited: 16
Clinically Significant Drug–Drug Interactions with Agents for Attention-Deficit/Hyperactivity Disorder
Georgios Schoretsanitis, José de León, Chin B. Eap, et al.
CNS Drugs (2019) Vol. 33, Iss. 12, pp. 1201-1222
Closed Access | Times Cited: 26
Page 1 - Next Page

Scroll to top